{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:58:03Z","timestamp":1790384283465,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2018,10,16]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              The likelihoods of valvular heart disease (\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              ) and conduction abnormalities in patients with ankylosing spondylitis (\n              <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>\n              p) are poorly defined. Knowing their lifetime risks of\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              and pacemaker use would help inform whether cardiac screening should be done.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Patients with\n              <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>\n              p and a comparison group without\n              <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>\n              p were identified among US Medicare beneficiaries in 1999 to 2013. Frequencies of\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              and pacemaker use were compared in 4 age groups: 65 to 69 years, 70 to 74 years, 75 to 79 years, and 80 years or older, as were rates of valve surgeries, a measure of\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              severity, and new pacemaker insertions. Outcomes were compared between 42\u00a0327 patients with\n              <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>\n              p and 19\u00a0211\u00a0703 patients without\n              <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>\n              p. The prevalence of aortic valve disease in patients with\n              <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>\n              p increased with age (2.6%, 6.7%, 10.9%, and 17.1%), as did the prevalence of mitral valve disease. Risks of\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              were slightly but significantly higher in patients with\n              <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>\n              p (adjusted odds ratios 1.06\u20131.51). Rates of aortic valve replacement\/repair were also higher in patients with\n              <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>\n              p than in the comparison group (125 versus 93; 183 versus 149; 261 versus 208; 279 versus 191 per 100\u00a0000 patient\u2010years in the 4 age groups). Rates of mitral valve surgery did not differ between groups. Among patients with\n              <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>\n              p, pacemaker use ranged from 1.0% to 7.6% across age groups, and was slightly higher than in controls (odds ratio range 1.11\u20131.32).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Lifetime risks of\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              and pacemaker use in\n              <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>\n              p increase markedly with age, but are only slightly higher than in elderly people without\n              <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>\n              p.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.118.010016","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T09:01:05Z","timestamp":1539248465000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":23,"title":["Lifetime Risks of Valvular Heart Disease and Pacemaker Use in Patients With Ankylosing Spondylitis"],"prefix":"10.1161","volume":"7","author":[{"given":"Michael M.","family":"Ward","sequence":"first","affiliation":[{"name":"Intramural Research Program National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institutes of Health Bethesda MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.6.705"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-8_Part_1-199710150-00007"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90497-4"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1983.tb00188.x"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00393-3"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.4250\/jcu.2012.20.1.30"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.04.032"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(82)91946-4"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1982.tb02416.x"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.5.652"},{"key":"e_1_3_1_12_2","first-page":"120","article-title":"Transthoracic and transesophageal echocardiographic evaluation of the aortic root and subvalvular structures in ankylosing spondylitis","volume":"23","author":"Arnason JA","year":"1996","unstructured":"Arnason JA, Patel AK, Rahko PS, Sundstrom WR. Transthoracic and transesophageal echocardiographic evaluation of the aortic root and subvalvular structures in ankylosing spondylitis. J Rheumatol. 1996;23:120\u2013123.","journal-title":"J Rheumatol"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.7.766"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/000331978803900702"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-1117-6"},{"key":"e_1_3_1_16_2","first-page":"171","article-title":"The carditis and aortitis of ankylosing spondylitis","volume":"9","author":"Graham DC","year":"1958","unstructured":"Graham DC, Smythe HA. The carditis and aortitis of ankylosing spondylitis. Bull Rheum Dis. 1958;9:171\u2013174.","journal-title":"Bull Rheum Dis"},{"key":"e_1_3_1_17_2","first-page":"1309","article-title":"Cardiovascular manifestations of ankylosing spondylitis","volume":"111","author":"Kinsella TD","year":"1974","unstructured":"Kinsella TD, Johnson LG, Sutherland RI. Cardiovascular manifestations of ankylosing spondylitis. CMAJ. 1974;111:1309\u20131311.","journal-title":"CMAJ"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90177-2"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a062058"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-14-237"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009740903096101"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.176.6.1761357"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22682"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3952"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000160417.39497.a9"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/03610911003650383"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69208-8"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.30581"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212189"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.282437"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.09.046"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20408"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.118.010016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T11:56:56Z","timestamp":1715601416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.118.010016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":31,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2018,10,16]]}},"alternative-id":["10.1161\/JAHA.118.010016"],"URL":"https:\/\/doi.org\/10.1161\/jaha.118.010016","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]},"assertion":[{"value":"2018-06-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e010016"}}